ferric ferrocyanide has been researched along with Benign Neoplasms in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (2.22) | 29.6817 |
2010's | 22 (48.89) | 24.3611 |
2020's | 22 (48.89) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Dang, Y; Feng, G; Fu, J; Lei, X; Wu, Q; Yu, XY | 1 |
Chen, X; Huang, H; Mu, X; Wang, D; Wei, S; Zhou, L | 1 |
Cao, Y; Chen, Q; Li, L; Liu, S; Liu, W; Ran, H; Shang, T; Tan, M; Wang, Z; Xie, Z; Zhang, L; Zhang, W | 1 |
Hao, Y; Liao, W; Liao, X; Mao, L; Yuan, M; Zhang, R | 1 |
Dong, X; Li, D; Li, L; Wang, C; Wang, T; Zhang, L | 1 |
Chen, X; Gong, X; Hou, L; Yang, J; Yang, W; Zhang, H | 1 |
Chen, S; Ge, J; Iqbal, MZ; Kong, X; Ma, Z; Wang, S; Wang, Y; Xie, F; Yang, X; Zhang, Q; Zhao, R; Zhong, D | 1 |
Jiang, XY; Liu, WF; Su, YY; Teng, ZG; Tian, W; Tian, Y; Wang, SJ; Yan, SY; Yang, YW; Yao, H; Zhang, LJ; Zheng, LJ | 1 |
Bao, Z; Guo, L; Liang, J; Sun, Y; Wang, D; Wang, K; Xu, H; Yuan, Y; Zhang, Y; Zheng, J | 1 |
Fang, Q; Hu, Y; Li, S; Li, X; Lu, N; Shao, J; Song, Y; Tang, K; Xiu, W; Yang, D; Zhang, J; Zhang, X | 1 |
Guan, P; Lian, H; Liu, X; Meng, Z; Mu, J | 1 |
Gai, S; Li, R; Li, W; Liu, S; Yang, P; Zhang, Y; Zhong, L; Zhou, J | 1 |
Liang, J; Shi, Y; Zhang, C; Zhang, X; Zhong, L; Zhou, Q; Zhou, X; Zhu, J | 1 |
Jo, S; Kim, S; Lee, H; Lee, S; Lee, TS; Lee, WJ; Lim, J; Park, JH; Yang, JK | 1 |
Hong, H; Im, HJ; Jeon, M; Kim, H; Kim, M; Lee, C; Lee, W; Piao, Y | 1 |
Catala, L; Fétiveau, L; Gazeau, F; George, R; Gloter, A; Laurent, S; Mejanelle, P; Muller, R; Nicolas-Boluda, A; Paul, G; Sancey, L; Volatron, J | 1 |
Chen, Y; Pu, Y; Shi, J; Wu, W; Yao, H; Yu, L | 1 |
Haque, S; Patra, CR | 1 |
Cheng, C; Gao, X; Han, X; Lin, S; Lin, T; Liu, C; Wang, Q | 1 |
Chen, X; Gao, MY; Hu, JM; Shen, AG; Shen, YM | 1 |
Chen, Y; Li, ZH; Sun, Y; Zhang, XZ | 1 |
Chen, B; Kankala, RK; Krastev, R; Li, X; Liu, Y; Long, R; Wang, P; Wang, S; Xiong, X; Yang, D; Zhang, Y; Zhu, M | 1 |
Li, J; Liu, R; Liu, Y; Sang, L; Wang, D; Wang, T; Wang, Z | 1 |
Hao, J; Wang, R; Wang, Z; Yang, Y; Zhang, N; Zou, H | 1 |
Chen, L; Hao, Y; Li, W; Peng, J; Qian, Z; Tan, L; Xiao, Y; Yang, Q | 1 |
Cai, K; Cao, H; Cao, Y; Chen, Q; Hao, L; Hou, Y; Huo, R; Li, K; Li, M; Lu, L; Luo, Z; Ran, H; Sutrisno, L; Xue, C; Zhou, J | 1 |
Jin, X; Jing, L; Qu, H; Yu, T; Zhu, C | 1 |
Gautam, M; Kim, JO; Poudel, K; Yong, CS | 1 |
Hou, M; Kang, Y; Sun, L; Xu, Z; Xue, P; Zhang, L | 1 |
Gao, Y; Hou, M; Kang, Y; Xu, Z; Xue, P; Yang, R; Zhang, L | 1 |
Liu, ZJ; Song, XX; Tang, Q | 1 |
Dai, Z; Deng, Z; Feng, S; Huang, M; Jing, L; Li, C; Li, X; Liang, X | 1 |
Chamorro, A; de la Escosura-Muñiz, A; de Torres, C; Espinoza-Castañeda, M; Merkoçi, A | 1 |
Cheng, L; Gong, H; Liu, G; Liu, J; Liu, Z; Wang, X; Zhu, W | 1 |
Cai, X; Chen, H; Chen, Y; Jia, X; Ma, M; Shi, J; Wang, S; Wu, H; Xu, H; Zhang, K | 1 |
Liu, J; Liu, X; Wu, L; Wu, M; Zeng, Y; Zhang, D | 1 |
Dai, Z; Jing, L; Shao, S; Wang, Y; Yang, Y; Yue, X | 1 |
Patra, CR | 1 |
Guari, Y; Guérin, C; Larionova, J; Long, J | 1 |
Jeong, YY; Lee, HG; Lee, JH; Sahu, A; Tae, G | 1 |
Bollard, CM; Burga, RA; Fernandes, R; Patel, S; Y Cruz, CR | 1 |
Feng, S; Li, X; Liang, X; Ma, F; Wang, J; Xing, S; Yue, X | 1 |
Gao, C; Ge, S; Wang, Y; Yan, M; Yu, J; Zhang, L | 1 |
Feng, S; Fu, G; Liu, W; Yue, X | 1 |
Arbab, AS; Bashaw, LA; Bulte, JW; Frank, JA; Jordan, EK; Miller, BR | 1 |
5 review(s) available for ferric ferrocyanide and Benign Neoplasms
Article | Year |
---|---|
Recent advances in Prussian blue-based photothermal therapy in cancer treatment.
Topics: Humans; Hyperthermia, Induced; Nanoparticles; Neoplasms; Phototherapy; Photothermal Therapy | 2023 |
The Application of Prussian Blue Nanoparticles in Tumor Diagnosis and Treatment.
Topics: Drug Delivery Systems; Ferrocyanides; Humans; Nanoparticles; Neoplasms | 2020 |
[Advances of Function of Prussian Blue Nano-materials in Cancer Diagnosis and Therapy].
Topics: Ferricyanides; Ferrocyanides; Humans; Nanostructures; Neoplasms | 2016 |
Prussian blue nanoparticles: Synthesis, surface modification, and application in cancer treatment.
Topics: Animals; Drug Delivery Systems; Drug Design; Drug Resistance; Ferrocyanides; Humans; Multimodal Imaging; Nanoparticles; Neoplasms | 2018 |
Prussian blue type nanoparticles for biomedical applications.
Topics: Animals; Coloring Agents; Ferrocyanides; Humans; Nanomedicine; Nanoparticles; Nanotechnology; Neoplasms; Optical Imaging; Tomography, Emission-Computed, Single-Photon | 2016 |
40 other study(ies) available for ferric ferrocyanide and Benign Neoplasms
Article | Year |
---|---|
Synergistic Therapy Using Doxorubicin-Loading and Nitric Oxide-Generating Hollow Prussian Blue Nanoparticles with Photoacoustic Imaging Potential Against Breast Cancer.
Topics: Animals; Doxorubicin; Ferrocyanides; Mice; Nanoparticles; Neoplasms; Nitric Oxide; Photoacoustic Techniques | 2021 |
Polycyclodextrin as a linker for nanomedicine fabrication and synergistic anticancer application.
Topics: Adamantane; Animals; Antineoplastic Agents; Cyclodextrins; Female; Ferrocyanides; HeLa Cells; Humans; Isoindoles; Light; Mice, Inbred BALB C; Nanomedicine; Nanoparticles; Neoplasms; Organometallic Compounds; Photosensitizing Agents; Polymers; Reactive Oxygen Species; Ytterbium; Zinc Compounds | 2021 |
Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Cell Survival; Docetaxel; Ferrocyanides; Humans; Imiquimod; Immunotherapy; Infrared Rays; Macrophages; Mice; Mice, Nude; Nanoparticles; Neoplasms; Optical Imaging; Photothermal Therapy; Polylactic Acid-Polyglycolic Acid Copolymer | 2021 |
Multifunctional Biodegradable Prussian Blue Analogue for Synergetic Photothermal/Photodynamic/Chemodynamic Therapy and Intrinsic Tumor Metastasis Inhibition.
Topics: Ferrocyanides; Humans; Neoplasms; Photochemotherapy; Photothermal Therapy | 2021 |
Designed formation of Prussian Blue/CuS Janus nanostructure with enhanced NIR-I and NIR-II dual window response for tumor thermotherapy.
Topics: Copper; Ferrocyanides; Humans; Hyperthermia, Induced; Nanoparticles; Nanostructures; Neoplasms; Phototherapy | 2022 |
Hybrid-Membrane-Decorated Prussian Blue for Effective Cancer Immunotherapy via Tumor-Associated Macrophages Polarization and Hypoxia Relief.
Topics: Ferrocyanides; Humans; Hypoxia; Immunotherapy; Mannose; Neoplasms; Tumor Microenvironment; Tumor-Associated Macrophages | 2022 |
A biomineralized Prussian blue nanotherapeutic for enhanced cancer photothermal therapy.
Topics: Animals; Calcium; Ferrocyanides; Mice; Nanoparticles; Neoplasms; Phototherapy; Photothermal Therapy | 2022 |
Hybrid Au-star@Prussian blue for high-performance towards bimodal imaging and photothermal treatment.
Topics: Animals; Cell Line, Tumor; Contrast Media; Ferrocyanides; Gold; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Phototherapy | 2023 |
Prussian Blue-Derived Nanoplatform for In Situ Amplified Photothermal/Chemodynamic/Starvation Therapy.
Topics: Catalysis; Cell Line, Tumor; Ferrocyanides; Glucose Oxidase; Glutathione; Humans; Hydrogen Peroxide; Nanoparticles; Neoplasms; Photothermal Therapy; Tumor Microenvironment | 2023 |
Metal-rich cascade nanosystem for dual-pathway ferroptosis resistance regulation and photothermal effect for efficient tumor combination therapy.
Topics: Combined Modality Therapy; Ferroptosis; Glucose Oxidase; Humans; Hydrogen Peroxide; Metals; Neoplasms | 2023 |
Dual-inhibition of lactate metabolism and Prussian blue-mediated radical generation for enhanced chemodynamic therapy and antimetastatic effect.
Topics: Biological Transport; Cell Line, Tumor; Cell Respiration; Ferrocyanides; Humans; Hydrogen Peroxide; Lactic Acid; Nanoparticles; Neoplasms; Tumor Microenvironment | 2023 |
Imaging application of an MMP2-sensitive tumor-targeted prussian blue fluorescent nanoprobe.
Topics: Ferrocyanides; Humans; Matrix Metalloproteinase 2; Neoplasms; Tumor Microenvironment | 2023 |
Silica-Based Platform Decorated with Conjugated Polymer Dots and Prussian Blue for Improved Photodynamic Cancer Therapy.
Topics: Humans; Neoplasms; Photochemotherapy; Polymers; Reactive Oxygen Species; Silicon Dioxide | 2023 |
Injectable biocompatible nanocomposites of Prussian blue nanoparticles and bacterial cellulose as a safe and effective photothermal cancer therapy.
Topics: Animals; Mice; Nanocomposites; Nanoparticles; Neoplasms; Phototherapy; Photothermal Therapy | 2023 |
Tailored ultra-small Prussian blue-based nanoparticles for MRI imaging and combined photothermal/photoacoustic theranostics.
Topics: Animals; Cell Line, Tumor; Contrast Media; Ferrocyanides; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms; Theranostic Nanomedicine; Transplantation, Heterologous | 2019 |
Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Copper; Disulfiram; Ferrocyanides; Humans; Infrared Rays; Mice; Nanomedicine; Nanoparticles; Neoplasms; Photosensitizing Agents; Photothermal Therapy; Porosity; Povidone; Survival Rate; Xenograft Model Antitumor Assays | 2020 |
Silver Prussian blue analogue nanomedicine for future cancer therapy.
Topics: Antineoplastic Agents; Drug Carriers; Ferrocyanides; Humans; Neoplasms; Silver; Theranostic Nanomedicine | 2021 |
Fine synthesis of Prussian-blue analogue coated gold nanoparticles (Au@PBA NPs) for sorting specific cancer cell subtypes.
Topics: Ferrocyanides; Gold; Metal Nanoparticles; Neoplasms; Spectrum Analysis, Raman | 2021 |
Platinum-Doped Prussian Blue Nanozymes for Multiwavelength Bioimaging Guided Photothermal Therapy of Tumor and Anti-Inflammation.
Topics: Ferrocyanides; Humans; Neoplasms; Phototherapy; Photothermal Therapy; Platinum | 2021 |
Cancer Cytomembrane-Cloaked Prussian Blue Nanoparticles Enhance the Efficacy of Mild-Temperature Photothermal Therapy by Disrupting Mitochondrial Functions of Cancer Cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Membrane; Cell Proliferation; Drug Carriers; Drug Liberation; Female; Ferrocyanides; Hep G2 Cells; Humans; Indazoles; Infrared Rays; Mice, Nude; Mitochondria; Nanocomposites; Nanoparticles; Neoplasms; Photothermal Therapy | 2021 |
Phase-change mesoporous Prussian blue nanoparticles for loading paclitaxel and chemo-photothermal therapy of cancer.
Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Ferrocyanides; Mice; Nanoparticles; Neoplasms; Paclitaxel; Phototherapy; Photothermal Therapy | 2021 |
Mesoporous composite nanoparticles for dual-modality ultrasound/magnetic resonance imaging and synergistic chemo-/thermotherapy against deep tumors.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cattle; Cell Death; Cell Line, Tumor; Combined Modality Therapy; Doxorubicin; Drug Liberation; Ferrocyanides; Fluorocarbons; High-Intensity Focused Ultrasound Ablation; Liver Neoplasms; Magnetic Resonance Imaging; Nanoparticles; Neoplasms; Porosity; Rabbits | 2017 |
Erythrocyte-Membrane-Coated Prussian Blue/Manganese Dioxide Nanoparticles as H
Topics: Doxorubicin; Erythrocyte Membrane; Ferrocyanides; Humans; Hydrogen Peroxide; Manganese Compounds; Nanoparticles; Neoplasms; Oxides; Oxygen; Phototherapy | 2017 |
Engineering of a Nanosized Biocatalyst for Combined Tumor Starvation and Low-Temperature Photothermal Therapy.
Topics: Animals; Drug Delivery Systems; Ferrocyanides; Glucose; Glucose Oxidase; Hep G2 Cells; Humans; Hydrogen Peroxide; Hyperthermia, Induced; Mice; Mice, Nude; Nanoparticles; Neoplasms; Oxygen; Phototherapy; Temperature | 2018 |
A paper-based photothermal array using Parafilm to analyze hyperthermia response of tumour cells under local gradient temperature.
Topics: Colorimetry; Ferrocyanides; HeLa Cells; Humans; Hyperthermia, Induced; Lasers; Low-Level Light Therapy; MCF-7 Cells; Nanoparticles; Neoplasms; Paper; Paraffin; Temperature | 2018 |
Indocyanine green-modified hollow mesoporous Prussian blue nanoparticles loading doxorubicin for fluorescence-guided tri-modal combination therapy of cancer.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Carriers; Drug Liberation; Female; Ferrocyanides; Humans; Indocyanine Green; Infrared Rays; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Nanoparticles; Neoplasms; Photochemotherapy; Porosity; Tissue Distribution | 2019 |
Folate grafted Prussian Blue entrapped with gadolinium(III) as a new contrast agent for tumor-targeted magnetic resonant imaging.
Topics: Animals; Cell Line; Colloids; Contrast Media; Dose-Response Relationship, Drug; Female; Ferrocyanides; Folic Acid; Gadolinium; Ions; Kidney; Ligands; Magnetic Resonance Imaging; Magnetics; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Transplantation; Neoplasms | 2013 |
Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer.
Topics: Animals; Ferrocyanides; Gold; HeLa Cells; Humans; Hyperthermia, Induced; Mice; Mice, Nude; Nanoparticles; Neoplasms; Photoacoustic Techniques; Phototherapy; Tomography, X-Ray Computed | 2014 |
Nanochannel array device operating through Prussian blue nanoparticles for sensitive label-free immunodetection of a cancer biomarker.
Topics: Biomarkers, Tumor; Biosensing Techniques; Ferrocyanides; Gold; Humans; Nanoparticles; Neoplasms; Parathyroid Hormone-Related Protein | 2015 |
PEGylated Prussian blue nanocubes as a theranostic agent for simultaneous cancer imaging and photothermal therapy.
Topics: Animals; Cell Line, Tumor; Ferrocyanides; Hyperthermia, Induced; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Nanostructures; Neoplasms; Photoacoustic Techniques; Phototherapy; Polyethylene Glycols | 2014 |
Perfluoropentane-encapsulated hollow mesoporous prussian blue nanocubes for activated ultrasound imaging and photothermal therapy of cancer.
Topics: Animals; Apoptosis; Biocompatible Materials; Cell Line, Tumor; Female; Ferrocyanides; Fluorocarbons; HeLa Cells; Humans; Hyperthermia, Induced; Infrared Rays; Mice; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Neoplasms; Phototherapy; Porosity; Transplantation, Heterologous; Ultrasonography | 2015 |
Nanocluster of superparamagnetic iron oxide nanoparticles coated with poly (dopamine) for magnetic field-targeting, highly sensitive MRI and photothermal cancer therapy.
Topics: Animals; Contrast Media; Dextrans; Dopamine; Ferric Compounds; Ferrocyanides; HeLa Cells; Hep G2 Cells; Humans; Indoles; Lasers; Magnetic Fields; Magnetic Resonance Imaging; Magnetite Nanoparticles; Metal Nanoparticles; Mice; Microscopy, Confocal; Microscopy, Electron, Transmission; Nanocomposites; Nanotechnology; Neoplasms; NIH 3T3 Cells; Phototherapy; Polymers; Spectroscopy, Near-Infrared; Temperature | 2015 |
Hyaluronic Acid Modified Hollow Prussian Blue Nanoparticles Loading 10-hydroxycamptothecin for Targeting Thermochemotherapy of Cancer.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Drug Carriers; Drug Therapy; Ferrocyanides; HeLa Cells; Humans; Hyperthermia, Induced; Nanoparticles; Neoplasms | 2016 |
Prussian blue nanoparticles and their analogues for application to cancer theranostics.
Topics: Animals; Drug Carriers; Drug Delivery Systems; Ferrocyanides; Humans; Nanoparticles; Neoplasms; Theranostic Nanomedicine | 2016 |
Prussian blue/serum albumin/indocyanine green as a multifunctional nanotheranostic agent for bimodal imaging guided laser mediated combinatorial phototherapy.
Topics: Animals; Cell Line, Tumor; Ferrocyanides; Fluorescent Dyes; Humans; Indocyanine Green; Lasers; Light; Male; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Optical Imaging; Particle Size; Phototherapy; Serum Albumin; Theranostic Nanomedicine | 2016 |
Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapy.
Topics: Antigen-Presenting Cells; Coculture Techniques; Coloring Agents; Epstein-Barr Virus Infections; Ferrocyanides; Herpesvirus 4, Human; Humans; Immunotherapy; Jurkat Cells; Lymphocyte Activation; Nanomedicine; Nanoparticles; Neoplasms; Phototherapy; T-Lymphocytes, Cytotoxic | 2016 |
Prussian Blue Modified PLA Microcapsules Containing R6G for Ultrasonic/Fluorescent Bimodal Imaging Guided Photothermal Tumor Therapy.
Topics: Animals; Capsules; Female; Ferrocyanides; Fluorescence; HeLa Cells; Humans; Hyperthermia, Induced; Lactic Acid; Male; Neoplasms; Phototherapy; Polyesters; Polymers; Rabbits; Ultrasonics | 2016 |
Self-powered sensing platform equipped with Prussian blue electrochromic display driven by photoelectrochemical cell.
Topics: Biosensing Techniques; Cell Line, Tumor; Colorimetry; Coloring Agents; Electrochemical Techniques; Electrodes; Ferrocyanides; Gold; Graphite; Humans; Hydrogen Peroxide; Nanotubes; Neoplasms; Titanium | 2017 |
Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy.
Topics: Ablation Techniques; Cell Survival; Ferrocyanides; HeLa Cells; Humans; Lasers; Nanoparticles; Neoplasms; Photosensitizing Agents | 2012 |
Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques.
Topics: Animals; Cell Differentiation; Cell Survival; Cell Transplantation; Coloring Agents; Cytoplasm; Dextrans; Drug Combinations; Ferrocyanides; Ferrosoferric Oxide; Humans; Indicators and Reagents; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Neoplasms; Osmolar Concentration; Oxides; Polylysine; Time Factors | 2003 |